Coeptis Therapeutics Holdings- Warrants (31/10/2025) EBIT

Coeptis Therapeutics Holdings- Warrants (31/10/2025) (COEPW) currently reports a EBIT of $-22M as of June 2026. That compares with $-12M in the prior-year period — down 79.4% year over year. That is below the sector sector average of $-22M. Use the charts on this page to explore Coeptis Therapeutics Holdings- Warrants (31/10/2025)'s EBIT history and peer comparisons.

Coeptis Therapeutics Holdings- Warrants (31/10/2025)'s EBIT decreased from $-12M to $-22M — a 79.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Coeptis Therapeutics Holdings- Warrants (31/10/2025)'s EBIT of $-22M is lower than the its sector sector average of $-22M. That is roughly 3.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Coeptis Therapeutics Holdings- Warrants (31/10/2025) reported $-22M in EBIT as of June 2026. That compares with $-12M in the prior-year period — down 79.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-22M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-22M. From there, open related valuation or income-statement pages for Coeptis Therapeutics Holdings- Warrants (31/10/2025), and consider following COEPW for alerts when major investors trade the stock.